Skip to content

Regular research of "body surface-meridian-Zangfu correlation" of governor and conception vessels in treating uterus and brain-Randomized controlled trial of the treatment of primary dysmenorrhea with conception vessels acupuncture

Regular research of "body surface-meridian-Zangfu correlation" of governor and conception vessels in treating uterus and brain-Randomized controlled trial of the treatment of primary dysmenorrhea with conception vessels acupuncture

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000890
Enrollment
Unknown
Registered
2024-12-29
Start date
2024-11-30
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary dysmenorrhea

Interventions

Ren pulse group:acupuncture
Non-ren pulse group:acupuncture
Non-point pseudoacupuncture group:pseudoacupuncture

Sponsors

Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to 35 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for PD; (2) Age range from 16 to 35 years old; (3) Menstrual cycle regularity (28 ± 7 days); (4) The average Visual Analog Scale (VAS) score for dysmenorrhea pain in the past 3 menstrual cycles is greater than 4; (5) I did not receive any other treatment during the first menstrual cycle before receiving this therapy and did not take painkillers sedatives or steroids within the two weeks before treatment; (6) Sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Confirmed through gynecological ultrasound and other related examinations that secondary dysmenorrhea is caused by pelvic inflammatory disease endometriosis uterine myopathy or other factors; (2) Pregnant or lactating women; (3) Merge patients with serious life-threatening primary diseases such as cardiovascular cerebrovascular liver kidney and hematopoietic systems as well as psychiatric patients; (4) Individuals with irregular menstrual cycles and intermittent dysmenorrhea; (5) Currently undergoing additional treatment whose efficacy affects the clinical efficacy criteria of this study.

Design outcomes

Primary

MeasureTime frame
Cox Menstrual Symptom Scale;

Secondary

MeasureTime frame
Short-Form McGill Pain Questionnaire;TCM syndrome integral of primary dysmenorrhea;

Countries

the People's Republic of China

Contacts

Public ContactYuxia Ma

Shandong University of Traditional Chinese Medicine

myxia1976@163.com+86 186 5311 5177

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026